Fennec Pharmaceuticals Inc. (FENC)

Market is closed

Sector: Biological Products, (No Disgnostic Substances)

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on May 14, 2025, 4:19 pm based on SEC 13F filings Last update: May 14, 2025, 4:19 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Harbert Management Raymond J. Harbert	466,869	$2,843,232		3.22%
2.	AIGH Investment Partners Orin Hirschman	361,005	$2,198,521		0.91%
3.	DG Capital Management Dov Gertzulin	84,213	$512,857	-93%	0.18%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Andrade	$0.00	12,500		104,271	2024-04-01	Filing
Raykov	$0.00	29,167		316,638	2024-04-01	Filing
Southpoint	$6.25	80,000	Large Shareholder	4,077,214	2020-05-04	Filing
Essetifin	$6.25	768,000	Large Shareholder	3,993,694	2020-04-30	Filing
Manchester	$10.23	2,000	Large Shareholder	1,674,614	2017-10-24	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Remaining Holdings	Date	Form 4
Raykov	$6.31	10,000	53,587	2025-05-05	Filing
Raykov	$5.25	10,000	61,156	2025-04-04	Filing
Raykov	$6.79	10,000	68,725	2025-03-05	Filing
Rallis	$6.82	1,186	53,020	2025-02-14	Filing
Raykov	$6.66	10,000	76,294	2025-02-05	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Rosalind Advisors, Inc.	1,782,844	$10,857,520	5.28%
2.	Blackrock, Inc.	1,250,288	$7,614,253	0%
3.	Vanguard Group Inc	964,620	$5,874,536	0%
4.	Geode Capital Management, Llc	311,332	$1,896,011	0%
5.	Northern Trust Corp	138,375	$842,704	0%